New China Life Insurance Company Ltd. (SHA:601336)
China
· Delayed Price · Currency is CNY 49.13
+0.22 (0.45%)
Apr 22, 2025, 2:45 PM CST
SHA:601336 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 45,894 | 45,597 | 56,878 | 161,314 | 156,443 | Upgrade
|
| Total Interest & Dividend Income | -15,890 | 15,089 | 5,237 | 57,288 | 39,368 | Upgrade
|
| Gain (Loss) on Sale of Investments | 33,600 | -18,925 | 1,468 | -45 | 7,032 | Upgrade
|
| Other Revenue | 1,496 | 321 | 1,137 | 1,570 | 938 | Upgrade
|
| Total Revenue | 65,100 | 42,082 | 64,720 | 220,127 | 203,781 | Upgrade
|
| Revenue Growth (YoY) | 54.70% | -34.98% | -70.60% | 8.02% | 18.18% | Upgrade
|
| Policy Benefits | 20,818 | 22,560 | 33,083 | 173,464 | 155,930 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 9,174 | 9,011 | - | 14,592 | 17,827 | Upgrade
|
| Selling, General & Administrative | 3,062 | 2,370 | - | 12,472 | 12,395 | Upgrade
|
| Other Operating Expenses | 713 | 622 | 3,861 | 3,042 | 811 | Upgrade
|
| Total Operating Expenses | 33,767 | 34,563 | 36,944 | 203,570 | 186,963 | Upgrade
|
| Operating Income | 31,333 | 7,519 | 27,776 | 16,557 | 16,818 | Upgrade
|
| Interest Expense | -3,166 | -2,086 | -1,173 | -800 | -1,350 | Upgrade
|
| Earnings From Equity Investments | - | - | -18 | - | 264 | Upgrade
|
| Currency Exchange Gain (Loss) | 80 | 113 | -4,506 | -116 | -241 | Upgrade
|
| Other Non Operating Income (Expenses) | -30 | -2 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 28,217 | 5,544 | 22,079 | 15,641 | 15,491 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3 | -1 | - | -5 | - | Upgrade
|
| Asset Writedown | - | - | - | -3 | - | Upgrade
|
| Other Unusual Items | -73 | -28 | - | 37 | - | Upgrade
|
| Pretax Income | 28,141 | 5,515 | 22,079 | 15,670 | 15,491 | Upgrade
|
| Income Tax Expense | 1,908 | -3,201 | 575 | 719 | 1,194 | Upgrade
|
| Earnings From Continuing Ops. | 26,233 | 8,716 | 21,504 | 14,951 | 14,297 | Upgrade
|
| Minority Interest in Earnings | -4 | -4 | -4 | -4 | -3 | Upgrade
|
| Net Income | 26,229 | 8,712 | 21,500 | 14,947 | 14,294 | Upgrade
|
| Net Income to Common | 26,229 | 8,712 | 21,500 | 14,947 | 14,294 | Upgrade
|
| Net Income Growth | 201.07% | -59.48% | 43.84% | 4.57% | -1.82% | Upgrade
|
| Shares Outstanding (Basic) | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 | Upgrade
|
| Shares Outstanding (Diluted) | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 | Upgrade
|
| EPS (Basic) | 8.41 | 2.79 | 6.89 | 4.79 | 4.58 | Upgrade
|
| EPS (Diluted) | 8.41 | 2.79 | 6.89 | 4.79 | 4.58 | Upgrade
|
| EPS Growth | 201.32% | -59.51% | 43.84% | 4.58% | -1.85% | Upgrade
|
| Free Cash Flow | 95,190 | 89,458 | 86,727 | 70,595 | 64,144 | Upgrade
|
| Free Cash Flow Per Share | 30.51 | 28.67 | 27.80 | 22.63 | 20.56 | Upgrade
|
| Dividend Per Share | 2.530 | 0.850 | 1.080 | 1.440 | 1.390 | Upgrade
|
| Dividend Growth | 197.65% | -21.30% | -25.00% | 3.60% | -1.42% | Upgrade
|
| Operating Margin | 48.13% | 17.87% | 42.92% | 7.52% | 8.25% | Upgrade
|
| Profit Margin | 40.29% | 20.70% | 33.22% | 6.79% | 7.01% | Upgrade
|
| Free Cash Flow Margin | 146.22% | 212.58% | 134.00% | 32.07% | 31.48% | Upgrade
|
| EBITDA | 32,337 | 8,537 | 28,886 | 17,382 | 17,698 | Upgrade
|
| EBITDA Margin | 49.67% | 20.29% | 44.63% | 7.90% | 8.69% | Upgrade
|
| D&A For EBITDA | 1,004 | 1,018 | 1,110 | 825 | 880 | Upgrade
|
| EBIT | 31,333 | 7,519 | 27,776 | 16,557 | 16,818 | Upgrade
|
| EBIT Margin | 48.13% | 17.87% | 42.92% | 7.52% | 8.25% | Upgrade
|
| Effective Tax Rate | 6.78% | - | 2.60% | 4.59% | 7.71% | Upgrade
|
| Revenue as Reported | - | - | 108,164 | 222,380 | 203,858 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.